BIAFW · Insider Trading
bioAffinity Technologies, Inc. Warrant
Every open-market purchase and sale reported by BIAFW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-14 | Maria Zannes | President & CEO | A | +37,037 | — |
| 2025-01-14 | James Michael Edwards | VP and CFO | A | +6,172 | — |
| 2025-01-14 | Steven Girgenti | Executive Chairman | A | +14,814 | — |
| 2025-01-14 | Xavier Trinidad Reveles | Chief Operating Officer | A | +21,604 | — |
| 2025-01-14 | Timothy P Zannes | Secretary, EVP, Gen. Counsel | A | +8,641 | — |
| 2024-11-05 | James Michael Edwards | VP and CFO | A | +100,000 | — |
| 2024-07-02 | Stuart Diamond | Director | A | +33,784 | — |
| 2024-07-02 | Steven Girgenti | Executive Chairman | A | +33,784 | — |
| 2024-07-02 | Jamie Platt | Director | A | +33,784 | — |
| 2024-07-02 | Robert A. Anderson | Director | A | +33,784 | — |
| 2024-07-02 | Peter S Knight | Director | A | +33,784 | — |
| 2024-07-02 | Maria Zannes | President & CEO | A | +33,784 | — |
| 2024-07-02 | Roby Joyce | Director | A | +33,784 | — |
| 2024-07-02 | Harvey Sandler Revocable Trust | 10%+ Owner | A | +33,784 | — |
| 2024-06-14 | Peter S Knight | Director | A | +8,296 | — |
| 2024-06-14 | Maria Zannes | President & CEO | A | +8,296 | — |
| 2024-06-14 | Stuart Diamond | Director | A | +8,296 | — |
| 2024-06-14 | Jamie Platt | Director | A | +8,296 | — |
| 2024-06-14 | Robert A. Anderson | Director | A | +8,296 | — |
| 2024-06-14 | Roby Joyce | Director | A | +8,296 | — |
| 2024-06-14 | Gary D Rubin | Director | A | +8,296 | — |
| 2024-06-14 | Steven Girgenti | Executive Chairman | A | +8,296 | — |
| 2024-04-24 | Timothy P Zannes | Secretary, EVP, Gen. Counsel | MIXED | +35,817 | +$324 |
| 2024-04-24 | Steven Girgenti | Director | MIXED | +31,410 | +$323 |
| 2024-04-24 | Maria Zannes | President & CEO | MIXED | +36,584 | +$324 |
| 2024-03-29 | Robert A. Anderson | Director | M | +64,848 | +$74.90K |
| 2024-03-29 | Steven Girgenti | Executive Chairman | A | +39,474 | +$60.00K |
| 2024-02-02 | Timothy P Zannes | Secretary, EVP, Gen. Counsel | A | +6,688 | — |
| 2024-02-02 | Xavier Trinidad Reveles | Chief Operating Officer | A | +16,720 | — |
| 2024-02-02 | Michael Philip Dougherty | Chief Financial Officer | A | +31,847 | — |
| 2024-02-02 | Steven Girgenti | Executive Chairman | A | +11,943 | — |
| 2024-02-02 | Vivienne I Rebel | Chief Sci. & Med. Officer, EVP | A | +31,847 | — |
| 2024-02-02 | Maria Zannes | President, CEO | A | +23,885 | — |
| 2024-01-24 | Mohsin Y Meghji | Director | A | +11,867 | +$18.75K |
| 2024-01-24 | Peter S Knight | Director | A | +24,535 | +$37.50K |
| 2024-01-24 | Robert A. Anderson | Director | A | +24,535 | +$37.50K |
| 2024-01-24 | Maria Zannes | President, CEO | A | +24,535 | +$37.50K |
| 2024-01-24 | Gary D Rubin | Director | A | +24,535 | +$37.50K |
| 2024-01-24 | Jamie Platt | Director | A | +12,668 | +$18.75K |
| 2024-01-24 | Joyce Living Trust | — | A | +24,535 | +$37.50K |
| 2024-01-24 | Stuart Diamond | Director | A | +24,535 | +$37.50K |
| 2024-01-24 | Steven Girgenti | Executive Chairman | A | +24,535 | +$37.50K |
| 2023-08-11 | Steven Girgenti | Executive Chairman | A | +54,707 | +$116.25K |
| 2023-07-06 | Robert A. Anderson | Director | A | +28,392 | +$56.25K |
| 2023-07-06 | Maria Zannes | President, CEO | A | +54,570 | +$106.25K |
| 2023-07-06 | Michael Philip Dougherty | Chief Financial Officer | A | +52,356 | +$100.00K |
| 2023-07-06 | Peter S Knight | Director | A | +28,392 | +$56.25K |
| 2023-07-06 | Mohsin Y Meghji | Director | A | +28,392 | +$56.25K |
| 2023-07-06 | Gary D Rubin | Director | A | +28,392 | +$56.25K |
| 2023-07-06 | Stuart Diamond | Director | A | +28,392 | +$56.25K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Steven Girgenti | Executive Chairman | 1,089,017 | $164.01K |
| Maria Zannes | President & CEO | 280,359 | $42.22K |
| James Michael Edwards | VP and CFO | 120,128 | $18.09K |
| Timothy P Zannes | Secretary, EVP, Gen. Counsel | 54,765 | $8.25K |
| Xavier Trinidad Reveles | Chief Operating Officer | 41,943 | $6.32K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BIAFW quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.